Diana Norden
About Diana Norden
Diana Norden is a Senior Research & Communications Scientist at Integral Molecular in Philadelphia, Pennsylvania, where she has worked since 2019. She holds a PhD in Biochemistry from The Ohio State University and has extensive research experience in monoclonal antibodies and scientific communication.
Work at Integral Molecular
Diana Norden has been employed at Integral Molecular since 2019, serving as a Senior Research & Communications Scientist. In this role, she focuses on advancing research initiatives and enhancing communication strategies within the organization. Her work involves the development of methodologies for antibody discovery and contributing to the understanding of monoclonal antibodies and their specificity. Integral Molecular is based in Philadelphia, Pennsylvania, and is known for its innovative research in the field of biopharmaceuticals.
Education and Expertise
Diana Norden earned her Bachelor of Science in Biochemistry from Campbell University, where she studied from 2006 to 2010. She furthered her education at The Ohio State University, obtaining a Doctor of Philosophy (PhD) in Biochemistry from 2010 to 2015. Her academic background provides her with a strong foundation in biochemical research, which she applies in her professional roles, particularly in the areas of antibody discovery and biopharmaceutical development.
Background
Diana Norden has a diverse professional background in research. She began her career as a Research Assistant at Los Alamos National Laboratory in 2010, where she worked for three months. Following this, she held a position as a Postdoctoral Research Associate at The Ohio State University Wexner Medical Center from 2010 to 2016. She then transitioned to a Postdoctoral Researcher role at Drexel University from 2016 to 2019, before joining Integral Molecular. This progression highlights her extensive experience in scientific research and development.
Research Contributions
Diana Norden has made significant contributions to the field of biopharmaceuticals, particularly in the area of monoclonal antibodies. She has co-authored a publication focused on testing for off-target binding in biopharmaceuticals, which is critical for ensuring the efficacy and safety of therapeutic agents. Additionally, her involvement in the development of methodologies for antibody discovery reflects her commitment to advancing research in this vital area of science.
Scientific Communication
In her role as a Senior Research & Communications Scientist, Diana Norden engages in scientific communication and the dissemination of research findings. This aspect of her work is essential for translating complex scientific concepts into accessible information for various stakeholders. Her efforts contribute to the broader understanding of biopharmaceutical research and its implications in the medical field.